Besides being classical agents used in AML, the first two are pyrimidine analogues, whose DNA incorporation could be promoted by pyrimidine starvation, while idarubicin could potentiate the proapoptotic activity of DHODH inhibitors. Here, DHODH is linked to acute myeloid leukemia.